(PharmaNewsWire.Com, June 05, 2018 ) Global Companion Diagnostic Devices Market:
Companion diagnostics are medical devices, often an invitro device and provides the information that essential for safe and effective use of the corresponding drug or biotechnology product. Companion diagnostics are often developed along with drugs to aid in selecting or excluding the patient groups for the treatment with particular drug on basis of their biological characters. Companion diagnostics are developed based on biomarkers technology to predict response or severe toxicity of the drugs or biotechnological compounds. Companion diagnostics are majorly used in oncology area.
Some of the factors like improved efficacy and safety profiles of drugs, Accelerated drug regulatory approvals, reduced healthcare expenditure and drug development costs, increasing partnerships between market players, government organizations and other research firms over the use of co diagnostics, emergence of new pharmaceuticals and diagnostics are driving the growth of the global companion diagnostics market. However, due to the regulatory uncertainty, complex clinical trial procedures and intellectual property issues in certain areas are the few issues which are restraining the growth of the global companion diagnostics devices market.
Global companion diagnostic devices are segmented on the basis of application, technology, end user and geographical region.
Based on the application, global companion diagnostic devices are segmented as: Breast Cancer Colorectal Cancer Lung Cancer Urology Melanoma Gastric Cancer Others
Based on the technology, global companion diagnostic devices are segmented as: Immunohistochemistry Molecular Diagnostics Insitu Hybridization FISH CISH RealTime PCR Gene Sequencing
Based on the enduser, global companion diagnostic devices are segmented as: Hospitals Diagnostic Centres Others
The global companion diagnostic devices market is highly fragmented due to the presence of several established large and small suppliers. The competition in the market will intensify during the forecast period as vendors adopt strategies like M&A to develop new technologies. Product approval and launch will also help to increase the volume of available diagnostic devices in the market. In addition, the vendors also work on differentiating their products based on quality, the accuracy of results, and other value added services as it will help them to gain a competitive edge over their peers.
Geographically, companion diagnostic devices market is segmented into five regions: North America, Europe, Latin America, AsiaPacific and Middle East & Africa. North America expected to be major market for companion diagnostics owing to growth innovative technologies in biomarkers, increase in R&D investment in the region. AsiaPacific and Europe are expected to grow at a significant rate owing to large patent and consumer base, increasing government initiatives developing healthcare infrastructure, and growing disposable income.
Some of the players in companion diagnostic devices market are F. HoffmannLa Roche Ltd.Switzerland, Qiagen Ltd. Germany, ARUP Laboratories U.S., Abbott Laboratories U.S., Biogenex Laboratories, Inc. U.S, Thermo Fisher Scientific U.S, Ventana Medical Systems Inc. U.S, Myriad Genetics Inc. U.S, and Danaher U.S and others.
In June 2015, Ventana Medical Systems, Inc. RocheGroup has received USFDA approval for its ventana alk cdx assay, companion diagnostic to aid in the identification of patients for, xalkori crizotinib Pfizer’s FDA approved targeted therapy
In July 2014, AstraZeneca collaborated with Roche to develop a plasmabased companion diagnostic test to support azd9291, for nonsmallcell lung cancer
In 2014, Ventana Medical Systems, Inc., collaborated with ImmunoGen, Inc. to develop biomarker assays and a companion diagnostic immunohistochemistry test IHC for one ImmunoGen’s product candidates
Table of Contents
Companion Diagnostic Market Report 2018
Executive Summary 2. Global Companion Diagnostic Market Introduction 3. Global Companion Diagnostic Market Dynamics 4. Global Companion Diagnostic Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 5. Global Companion Diagnostic Market, By Product Type, 2013 2017 and Forecast, 2018 – 2024 Revenue, USD Mn To be continuing….!!!
Planet Market Reports gives statistical surveying reports to businesses, people and associations with a goal of helping them in their decision making process. We have huge database of market research reports & company profiles across globe. We associated with global market research a publisher who has a wide range of research specialists & industry experts which provides you deeper penetration of market research industry.
We have statistical surveying reports from number of top publishers and update our reports collections on daily basis with most recent research data to furnish our customers with the moment online access to our database. With access to this database, our customers will be able to benefit from expert insights on worldwide businesses, items, and market patterns. We help you in your buy choice by mapping your data needs with our immense accumulation of reports.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
